CEREVEL THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Accounts Payable
CEREVEL THERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Accounts Payable of -$1.19 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2024-05-08
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2024-03-31 was -$1.19M.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2023-12-31 was $279.00K.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2023-09-30 was $2.50M, a 33.85% decline year-over-year.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2023-06-30 was $2.03M, a 31.45% decline year-over-year.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2023 was $2.04M.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2022 was -$763.00K, a 110.48% decline from fiscal 2021.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2021 was $7.28M, a 413.62% increase from fiscal 2020.
- CEREVEL THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2020 was $1.42M, a 133.44% increase from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 4 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 7 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|
| 2024-03-31 | -$1.19M 10-Q · filed 2024-05-08 | -$915.00K derived: sum of 2 quarters · filed 2024-05-08 | $1.58M derived: sum of 3 quarters · filed 2024-05-08 | $3.61M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2023-12-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $2.77M derived: sum of 2 quarters · filed 2024-02-27 | $4.81M derived: sum of 3 quarters · filed 2024-02-27 | $2.04M 10-K · filed 2024-02-27 | ||
| 2023-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $4.53M derived: sum of 2 quarters · filed 2023-11-01 | $1.76M 10-Q · filed 2023-11-01 | -$3.24M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2023-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$737.00K 10-Q · filed 2023-08-02 | -$5.74M derived: sum of 3 quarters · filed 2024-05-08 | -$1.96M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2023-03-31 | -$2.77M 10-Q · filed 2024-05-08 | -$7.77M derived: sum of 2 quarters · filed 2024-05-08 | -$4.00M derived: sum of 3 quarters · filed 2024-05-08 | -$1.03M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.23M derived: sum of 2 quarters · filed 2024-02-27 | $1.74M derived: sum of 3 quarters · filed 2024-02-27 | -$763.00K 10-K · filed 2024-02-27 | ||
| 2022-09-30 | $3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $6.74M derived: sum of 2 quarters · filed 2023-11-01 | $4.24M 10-Q · filed 2023-11-01 | $9.64M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $464.00K 10-Q · filed 2023-08-02 | $5.87M derived: sum of 3 quarters · filed 2024-02-27 | $6.26M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | -$2.50M 10-Q · filed 2023-05-03 | $2.90M derived: sum of 2 quarters · filed 2024-02-27 | $3.29M derived: sum of 3 quarters · filed 2024-02-27 | $1.60M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $5.79M derived: sum of 2 quarters · filed 2024-02-27 | $4.10M derived: sum of 3 quarters · filed 2024-02-27 | $7.28M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $389.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.30M derived: sum of 2 quarters · filed 2022-11-08 | $1.87M 10-Q · filed 2022-11-08 | $2.71M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-06-30 | -$1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $1.49M 10-Q · filed 2022-08-01 | $2.32M derived: sum of 3 quarters · filed 2023-02-22 | -$398.00K derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-03-31 | $3.18M 10-Q · filed 2022-05-10 | $4.01M derived: sum of 2 quarters · filed 2023-02-22 | $1.29M derived: sum of 3 quarters · filed 2023-02-22 | -$213.00K derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2020-12-31 | $836.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$1.88M derived: sum of 2 quarters · filed 2023-02-22 | -$3.39M derived: sum of 3 quarters · filed 2023-02-22 | $1.42M 10-K · filed 2023-02-22 | ||
| 2020-09-30 | -$2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$4.22M derived: sum of 2 quarters · filed 2021-11-10 | $151.79K 10-Q · filed 2020-11-16 | $581.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $3.67K 10-Q · filed 2020-08-14 | $3.30M 10-Q · filed 2021-08-11 | |||
| 2020-03-31 | $4.81M 10-Q · filed 2021-05-17 | |||||
| 2019-12-31 | $607.00K 10-K · filed 2022-03-01 |